{"id":"W4405044004","doi":"10.1182/blood-2024-198403","title":"Mezigdomide (MEZI) in Novel-Novel Combinations for Relapsed or Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Pomalidomide; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science); Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000756235,0.0004603458,0.000789258,0.0002065189,0.0002211885,0.0005889421,0.0004148411,0.0004299451,0.002509775],"category_scores_gemma":[0.0003995455,0.0001828083,0.000927051,0.0003175148,0.0003205109,0.0005090956,0.0002691928,0.001601733,0.0004025906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007111037,"about_ca_system_score_gemma":0.00068736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001050126,"about_ca_topic_score_gemma":0.007059689,"domain_scores_codex":[0.9998347,0.00006255253,0.00001325424,0.00002875122,0.00002561562,0.00003510874],"domain_scores_gemma":[0.9997846,0.0000411276,0.00004430394,0.00001645403,0.00001546537,0.00009792171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5140769,0.009887592,0.01216732,0.002556693,0.004095069,0.0004025325,0.0003868073,0.00396495,0.04426748,0.0009620574,0.01412139,0.3931112],"study_design_scores_gemma":[0.6679609,0.2377385,0.04799024,0.0003201836,0.002841047,0.0009766421,0.0001325132,0.002564672,0.007837462,0.0006699382,0.03090787,0.00006004224],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760085,0.01509344,0.0005389832,0.0009668641,0.0001570448,0.0008201515,0.00184195,0.0001420032,0.004430932],"genre_scores_gemma":[0.9836158,0.00756002,0.001265643,0.0009457837,0.0001574183,0.0006823096,0.0030288,0.00002468515,0.002719574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002509775,"threshold_uncertainty_score":0.008396029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06561095051632172,"score_gpt":0.3324392768429464,"score_spread":0.2668283263266247,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}